Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.–(BUSINESS WIRE)–August 29, 2017– Augmenix, Inc., a ...
Prostate cancer is currently one of the most common cancers in the UK; more than 40,000 cases are diagnosed each year. Typical treatment plans include a high dose of radiotherapy that aims to ...
Results published in the International Journal of Radiation Oncology Biology and Physics show on average no long-term declines in bowel and urinary quality of life for patients and 78% reduction in ...
SpaceOAR Hydrogel reduces radiation exposure to the rectum, minimizing bowel-related side effects in prostate cancer patients undergoing radiation therapy. A study showed a 25% reduction in bowel ...
The instrument Dr. Matthew Emme held in his hand was wire-thin like a needle, but long like a dagger. Dick Blondo leaned far out of his chair, scrutinizing the needle — for that is what it was — with ...
Injection of a hydrogel spacer to provide prostate-rectum separation during radiation therapy for prostate cancer is associated with decreased radiation-induced rectal toxic effects, according to a ...
Dr. Varun Sundaram of Urology Austin spoke with Studio 512 Co-Host Rosie Newberry about prostate cancer, what you can do if you have been diagnosed, as well as treatments including “SpaceOAR™ Hydrogel ...
Prostate cancer is the second most common cancer for American men, yet receiving a diagnosis can feel unexpected. [1] While some people experience symptoms like increased frequency of difficulty ...
According to the American Cancer Society (ACS), prostate cancer is the second most common cancer in American men and the second-leading cause of cancer-related death in the U.S. More than 164,000 new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback